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Whether this sort of activity will become widespread in
South Africa is questionable, given the lack of incentives.
The CHC and the community it serves received no financial
benefit from the more economical prescribing during this
study. Perhaps one way to encourage more cost-effective
prescribing is to learn from the UK experience with
fundholding GPs" and to allow all or a proportion of savings
from drug costs to be used to fund improvements in
services and facilities of the institution making the savings.
We would like to thank all the doctors at the day hospital,
especially Dr K Ahmad and Dr R Evans for their participation in
the study, and all the clinic staff for their co-operation,
particularly the nursing and pharmacy staff. We would also like
to thank the Cardiology Unit of the Department of Medicine,
University of Stellenbosch, for funding the data analysis and the
writing up for publication.
REFERENCES
1. African National Congress. A National Health Plan for South Africa.
Johannesburg: African National Congress, 1994.
2. Seedat YK, Seedat MA, Hackland 08T. Prevalence of hypertension in the urban
and rural Zulu. J Epidemio! Community Health 1982; 36: 256-261.
3. Steyn K. The epidemiology of hypertension in South Africa and the implications
for clinical practice. Proceedings of the Advanced Course in Medicine, The
College of Medicine of South Africa, November 1991.
4. Heart Foundation Hypertension Consensus Symposium. Management guidelines
for hypertension in southern Africa. S Afr Med J 1992; 82 (Qct): suppl, 1~4.
5. World Health Organisation. 1993 Guidelines for the management of mild
hypertension: memorandum from a WHO/ISH meeting. Bull World Health Organ
1993; 71: 503-517.
6. Joint National Committee on Detection, Evaluation, and Treatment of High Blood
Pressure: The fifth report of the Joint National Committee on Detection,
Evaluation and Treatment of High Slood Pressure. Arch Intern Med 1993; 153:
154-183.
7. Hypertension Society of Southern Africa. Guidelines for the management of
hypertension at primary health care level. S Afr Med J 1995; 85: 1321-1325.
8. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart
disease. Part 2. Short term reductions in blood pressure: overview of randomised
drug trials in their epidemiological context. Lancet 1990; 335: 827 -838.
9. Pearson TA, Jamison DT, Trejo-Gutierrez J. Cardiovascular disease. In: Jamisan
DT, Masley WH, Measham AA, Sabadilla J-L, eds. Disease Control Priorities In
Developing Countries. New York: Oxford University Press, 1993.
10. Fletcher A. Economics of hypertension control: a statement by the World
Hypertension League. J Hum Hypertens 1994; 8: 789-795.
11. Menard J, Cornu P, Day M. Cost of hypertension treatment and the price of
health. J Hum Hypertens 1992; 6: 447-458.
12. Opie LH, Steyn K. Rationale for the Hypertension Guidelines for primary care in
South Africa. S Air Med J 1995; 85: 1325-1338.
13. Opie LH. The total costs and demands of treatment of hypertension in South
Africa. S Afr Med J 1989; 76: 85-88.
14. Keeton GR, Monteagudo MT. Significant cost-saving with modification of anti-
hypertensive therapy. S Atr Med J 1991; 80: 176-178.
15. Lunt DWR, Edwards PR, Steyn K, Lombard CJ, Fehrsen GS. Hypertension care at
a Cape Town Community Health Centre. S Atr Med J 1998; 88: 544-548 (this
issue).
16. Department of Pharmacology, University of Cape Town. South African Medicines
FormUlary. 2nd ed. Cape Town: Medical Association of South Africa, 1991.
17. Pick W, Myers J, Saved R, Dhansay J, George R, Barday A. The epidemiology of
hypertension in family practice in Cape Town. S Afr Med J 1990; 78: 7-10.
18. Smith J, Nel P, Joelson L. Hypertension management in a Cape Peninsula
coloured community. S Atr Med J 1987; 72: 530-532.
19. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on
the quality of life. N Engl J Med 1986; 314: 1657-1664.
20. Materson BJ, Reda DJ, Cushman WC, et al. Single drug therapy for hypertension
in men: a comparison of six antihypertensive agents with placebo. N Engl J Med
1993; 328: 914-921.
21. Delamothe 1. Wanted: guidelines that doctors will follow. BMJ 1993; 307: 218.
22. Effective Health Care. Implementing Clinical Practice Guidelines.- Can Guidelines
Be Used To Improve Clinical Practice? (Bulletin No. 8). Leeds: University of
Leeds, 1994.
23. McWhinney lA. A Textbook of Family Medicine. New York: Oxford University
Press. 1989.
24. Dowell JS, Snadden 0, Dunbar JA. Changing to generic formular/: how one
fundholding practice reduced prescribing costs. BMJ 1995; 310: 505-508.
Accepted 14 Apr 1997.
Survival of children in Cape
Town known to be vertically
infected with HIV-1
G D Hussey, R M Reijnhart, A M Sebens,
J Burgess, S Schaaf, S Potgieter
Objective. To determine the survival patterns of children in
Cape Town known to be vertically infected with HIV.
Design. Retrospective record review of children
diagnosed with symptomatic HIV infection during the
period 1 December 1990 - 31 May 1995.
Setting. Hospitals in the Cape Town metropolitan area.
Patients. 193 children were known to be vertically HIV-
infected. HIV diagnosis was based on the following
criteria: two positive HIV enzyme-linked immunosorbent
assays (ELlSAs) in children older than 15 months and a
positive ELlSA together with a positive polymerase chain
reaction (PCR) in younger children. The mothers of the
children were known to be HIV-positive. On the basis of
the presenting clinical findings children were assigned to a
disease severity category (A, B or C) according to the
Centers for Disease Control and Prevention (CDC)'s 1994
revised classification system for HIV infection in children.
Outcome measures. Survival was analysed according to
the Kaplan-Meier method. Survival time was defined as
the length of time between clinical diagnosis of HIV and
death or last contact with the health services. Mortality
risk in relation to specific variables at diagnosis such as
age and clinical manifestations was determined by
calculation of odds ratios (ORs) with 95% confidence
intervals (Cls).
Results. The median age at diagnosis was 5 months;
72% of children were aged less than 1 year at diagnosis.
According to the CDC clinical classification, 47 (24%) fell
into category A, 111 (58%) into category Band 35 (18%)
into category C. Of the 193 patients 85 (44%) were alive at
the time of review, 65 (34%) had died and 43 (22%) were
lost to fOllOW-Up. Risk of death was significantly
associated with age less than 6 months (OR 4.7,
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Cl 2.1 - 10.3) and severe disease, Le. CDC category C (OR
2.7; Cl 1.1 - 6.9) at time of diagnosis. The median survival
for all the children from time of diagnosis was 32 months.
Infants diagnosed before 6 months of age had significantly
shorter median survival (10 months) conipared with 36
months for those diagnosed at 7 - 12 months of age. For
the children over the age of 12 months the cumulative
proportion surviving at 48 months was 78%. Children with
severe disease (category C) had a median survival of 21
months, significantly lower than that in category B (32
months). For the children in category A the cumulative
proportion surviving at 48 months was 66%.
Conclusion. The median survival of children with HIV
was 32 months from time of diagnosis, and survival was
influenced by age and disease severity.
S Atr Med J 1998; 88: 554-558.
HIV infection is having a major impact on child health and
survival, particularly in Africa. In a study from 10 countries in
Central and East Africa AIDS is projected to cause between
a quarter and half a million additional deaths in children
under 5 years of age by the year 2000. The projected under-
5 mortality rates of between 159 and 189/1 000 will be
significantly higher than the previous target of 98 - 132 set
by the United Nations.' In recent studies from Abidjan2 and
Uganda' the infant mortality rates for children born to HIV-
infected women were 151 and 163/1 000, respectively,
compared with 34/1 000 (in both studies) for children of
seronegative mothers. In addition, studies from Lusaka and
Abidjan4 have shown that the risk of an infected child dying
in hospital was more than twofold greater than that for a
non-infected child. It has been estimated that up to 75% of
all HIV-infected children in Africa will die before their 5th
birthday.' The HIV epidemic in Africa has also resulted in an
additional burden to health services, with increasing
numbers of sick children presenting to facilities at all levels
of care.6
In South Africa vertically acquired HIV infection has
become a major public health problem. The most recent
national seroprevalence survey (1995) indicated that 10.4%
of women attending antenatal clinics were infected.' This
translates to approximately 40 000 HIV-infected infants for
1995. Published data on disease and survival patterns of
vertically HIV-infected children are lacking in South Africa.a.g
Such data are essential in planning and evaluating rational
strategies for intervention and resource allocation,
particularly in relation to provision of secondary and tertiary
care.
The purpose of this study is to report the natural history of
children in Cape Town known to have perinatally acquired
HIV infection, with a focus on survival patterns.
Methods
The medical records of all children with clinically
symptomatic vertically acquired HIV infection seen in Cape
Town hospitals during the 54-month period 1 December
1990 - 31 May 1995 were reviewed. Approximately 85% of
the patients were known to the Red Cross War Memorial
Children's Hospital infectious diseases clinic, which was set
up in 1991 in order to follow up these children. The rest
were followed up at a similar clinic at Tygerberg Hospital.
None of the children reviewed had received routine
antiretroviral or immunoglobulin therapy. Children infected
via horizontal transmission of the virus, patients with
doubtful or incomplete laboratory data and asymptomatic
vertically infected infants were excluded from the study.
The diagnosis of vertically acquired HIV infection was
based on the following criteria: two positive HIV enzyme-
linked immunosorbent assays (ELlSAs) in children older than
15 months and a positive ELlSA together with a positive
polymerase chain reaction (PCR) in younger children. In
addition, the mothers of children included in the study had
to be known to be HIV-positive.
Sociodemographic details, age and clinical findings at first
diagnosis were documented. On the basis of the presenting
clinical findings children were assigned to a disease severity
category (A - mild, B - moderate and C - severe)
according to the Centers for Disease Control and Prevention
(CDC)'s 1994 revised classification system for HIV infection
in children.'o Date of death or last contact with health
services was recorded.
Data analysis
Data were collated and analysed on computer using Epi-Info
version 6 and Statistica programs. Categorical and
continuous data were assessed by the c2 test and the non-
parametric Kruskal-Wallis test, respectively. Mortality risk in
relation to specific variables such as age and clinical
manifestations was determined by calculation of odds ratios
(ORs) with 95% confidence intervals (Cls). Survival analysis
was done according to the Kaplan Meier method and
stratified according to age and clinical stage at diagnosis.
The log rank test was used to determine whether statistical
differences existed between the groups. Survival time was
defined as the length of time between clinical diagnosis of
HIV infection and death or last contact with the health
services.
Results
Virtually all the 193 patients enrolled in the study were from
a disadvantaged socio-economic background. Nearly one-
third live in Khayelitsha, a sprawling peri-urban area outside
Cape Town. The male/female ratio was 1.2.
The age distribution of the children at diagnosis is shown
in Fig. 1. The median age at diagnosis was 5 months, with a
range of less than 1 month to 58 months; 72% were aged
less than 1 year at diagnosis. In 52% of cases the diagnosis
was made on first admission to hospital. The median
number of hospital admissions following HIV diagnosis was
2, and 12% of patients had 5 or more hospital admissions.
At diagnosis, 30.4% of the children were marasmic
« 60% of expected weight for age), 64.2% were
underweight for age (between 60% and 80% of expected
weight for age) and only 7.4% were above the third
percentile. No cases of kwashiorkor were noted. Diarrhoeal
disease and acute respiratory tract infections were the most
common presenting complaints, occurring in 47% and 44%
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This retrospective study provides survival data and the
relationship of survival with age and clinical findings at the
time of diagnosis for a large number of children who were
vertically infected with HIV in the Cape Town metropolitan
area. The clinical manifestations of children with HIV disease
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The median (25th, 75th centiles) age at diagnosis of
children known to have died was 4 (2, 7) months, with a
range of less than 1 month to 49 months. The median time
from diagnosis to death was 3 months, with a range of
between less than 1 month and 46 months. Seventy two per
cent of those who died did so by 12 months of age, and
88% were dead by 2 years of age. In contrast the median
age at diagnosis of children known to be alive (at June 1995)
was 8.5 (4, 18) months, with a range of less than 1 month to
54 months. Children who died were therefore significantly
younger at diagnosis than the survivors (P < 0.001).
Analysis of survival patterns (utilising the Kaplan-Meier
method) from diagnosis of HIV in relation to age and clinical
category are shown in Figs 2 and 3, respectively. The
median survival for all the children from time of diagnosis
was 32 months. Young infants (age < 6 months) had a
significantly shorter median survival period (10 months)
compared with 36 months for children aged 7 - 12 months
(P < 0.001). For children over the age of 12 months the
cumulative proportion surviving at 48 months was 78% (Fig.
2.). Children with severe disease (category C) had a median
survival of 21 months, significantly less than that in category
B (32 months) (P = 0.02). For the children in category A the
cumulative proportion surviving at 48 months was 66%
(Fig. 3).
Fig. 2. Survival of children according to age at diagnosis of HIV.
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Fig. 1. Age distribution of children at diagnosis of HIV infection.
of cases, respectively. The most common clinical finding
was hepatomegaly (83% of cases), followed by
lymphadenopathy (67%), splenomegaly (50%),
dermatological problems (45%) and oral thrush (34%).
Tuberculosis was diagnosed in 49% of children at the time
of HIV diagnosis. According to the CDC's clinical
classification 47 (24%) fell into category A, 111 (58%) into
category Band 35 (18%) into category C.
Of the 193 patients 85 (44%) were alive at the time of
review (June 1995), 65 (34%) had died and 43 (22%) were
lost to follow-up. The outcome of children according to year
of diagnosis and age and clinical category at diagnosis is
outlined in Table L None of the children diagnosed in 1990
have survived and at least 30% of those diagnosed between
1991 and 1994 are known to be dead, while 20% of those
diagnosed in 1995 have died. Risk of death was significantly
associated with age less than 6 months (OR 4.7; Cl 2.1 -
10.3) or severe disease, i.e. CDC category C (OR 2.7;
Cl 1.1 - 6.9) at time of diagnosis. The mortality risk remained
significant (but with a lower OR) if children who were lost to
follow-up were regarded as having died.
Table I. Outcome of HIV-infected children according to age, year
of diagnosis and CDC clinical category
Lost to
Dead Alive follow-up Total
No. of children 65 85 43 193
Year of diagnosis
1990 4 0 0 4
1991 7 6 6 19
1992 11 9 15 35
1993 11 11 11 33
1994 27 36 11 74
1995- 5 23 0 28
Age at diagnosis' 4 8 5 5
(2,7) (3,18) (2, 16) (2,18)
<6mo. 48 33 23 104
7 - 12 moo 12 18 7 37
> 12 moo 5 34 13 52
Clinical category
A 9 25 13 47
B 39 50 22 111
C 17 10 8 35
• Refers to the first 5 months of the year only.
t Median age (25th, 75th centiles) at diagnosis for dead and alive children were
significantly different (P < 0.001).
20 Percentage of cases
10
15 .....••.......................•........................
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children whose HIV infection had been recognised because
of their severe illness and who had presented to health
facilities. More comprehensive recent data obtained from
prospective cohort studies in developed countries suggest
that the incubation period may be in the region of about 4 -
5 years.""· What is significant about our data is the finding
that children with severe disease or children who were aged
less than 6 months at diagnosis had a higher risk of death
(ORs 4.7 and 2.7, respectively) which is similar to findings
reported previously.13.15 In the New York study the relative
risk of death in the most severe versus the least severe
group was 3.3 and for children under 6 months old
compared with older children the risk was 1.8. '3
Even though study designs have differed, the available
data from prospective cohort studies in developed countries
indicate that the median survival of children with vertically
acquired HIV infection from the time of diagnosis is in
excess of 5 years, while in Africa it is significantly shorter. In
one study from Italy 70% of perinatally infected children
were alive at 6 years and 50% at 9 years." In the USA it has
been estimated that a child born with HIV has a 75%
chance of surviving to 5 years of age." On the other hand,
the median survival in Uganda3 was reported to be 21
months and in Kenya it was about 4 years," which is similar
to survival in this study. The difference in survival is clearly
related to the availability and accessibility of medical and
other supportive care. In addition, the rapid advances in
antiretroviral therapy in developed countries promises to
increase survival rates significantly. This option is not
feasible in Africa at this moment, or for the foreseeable
future, given the high cost of such interventions.
In our study, which was a retrospective study of children
known to be HIV-infected, the median survival was 32
months. Survival was shorter in younger children and in
those with severe disease. Of the 16 children under 6
months old who also had severe disease (CDC category Cl
15 (94%) are known to have died, all except 2 within 6
months of diagnosis and before the age of 1 year. In the
absence of specific antiretrovial therapy and within the
context of scarce resources, these data suggest that we
should provide only palliative care for these children, ideally
within a primary care setting, and not subject them to
hospital admission and intensive or high-care therapy:o On
the other hand, current data indicate that there is a group of
children who appear to have a good outcome. For these
children, who were first diagnosed after their first birthday,
the cumulative proportion surviving 48 months after
diagnosis was 78%. This suggests that we should be
looking at strategies to improve the quality and duration of
life of these children as well as those who present with mild
disease. Ensuring adequate nutrition, psychosocial support
and accessibility to medical care, particularly for preventive
interventions such as immunisation and prophylaxis for
common paediatric illnesses, are important in reducing
morbidity from the common complications of HIV. Evaluation
of such strategies will be important, since as would be
expected with the unfolding of epidemic, more older children
will present to our health services. Ultimately the control of
the paediatric HIV epidemic will be dependent upon
reducing the heterosexual spread of HIV among the adult
population and minimising perinatal transmission from
infected mothers to infants.
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in this study is similar to that described in the rest of
Africa.·· 11 Acute respiratory tract infections, diarrhoea,
malnutrition, lymphadenopathy, splenomegaly or dermatitis
were present in over 40% of cases at initial diagnosis. One
of the shortcomings of this study was that the true extent of
AIDS-defining conditions such as lymphoid interstitial
pneumonitis, Pneumocystis carinii pneumonia,
encephalopathy and opportunistic infections other than
tuberculosis could not be quantified, because investigations
for such conditions were not part of routine clinical practice
in the period under review. In addition the study focused on
the common clinical findings at presentation and outcome
and did not include a formal evaluation of radiological
findings. Since most of these conditions would result in the
classification of patients into CDC clinical category C, our
clinical categorisation probably underestimates the true
extent to which children presented with severe signs and
symptoms.
The other major limitation of our study was that it was a
retrospective record review of children known to be HIV-
positive. As such it does not represent a true picture of the
survival pattern of all children with vertically acquired
infection. Nevertheless, it does provide useful
epidemiological data on the evolution of the epidemic in our
area. The median time period from birth to diagnosis was 5
months, with 72% presenting before the age of 1 year. This
probably reflects the early stage of the epidemic in the area,
and what we are currently seeing is the severe end of the
spectrum. In the early 1980s the published data from the
USA reported short incubation periods (6 - 9 months).'2.13
These studies were also biased in that they focused on
Survival TIme in Months
Fig. 3. Survival of children according to CDC clinical criteria at
diagnosis of HIV.
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Review Article
Electron beam computed
tomography for the
diagnosis of cardiac
disease
Yadon Arad
Electron beam computed tomography (EBCT) of the heart
is a new modality which will alter the way cardiology is
practised. It allows for the detection of early coronary
artery disease (CAD) in asymptomatic individuals,
regardless of their level of risk as assessed by traditional
risk factor analysis. Compared with risk analysis based on
risk factors alone, an assessment which also utilises
quantitative measurements of coronary artery plaque by
EBCT allows for more precise determination of the need
for medical therapy. Non-invasive intravenous contrast
EBCT coronary angiography can identify significant
obstructive CAD, and should reduce the need for
conventional coronary angiography. Incorporation of EBCT
into routine medical practice is more cost-effective than
other modalities currently available.
This paper reviews relevant original articles on EBCT
and preventive cardiology published in peer-reviewed
medical journals, and assesses the implications of EBCT
for preventive cardiology.
S Afr Med J 1998; 88; 558-563.
Limitations of traditional
evaluation of coronary heart
disease
Coronary artery disease (CAD) is the leading cause of death
in developed countries. Despite marked progress in the
diagnosis and treatment of CAD, its detection is limited by
the high incidence of silent, preclinical disease. In up to 50%
of patients the first symptom of atherosclerotic
cardiovascular disease is either an acute myocardial
infarction (MI) or sudden death.' Furthermore, although
subjects with a higher degree of obstruction may
subsequently be more likely to suffer a cardiac event,
angiography shows that half of those with a first or a fatal MI
have less than 50% coronary obstruction. This apparent
paradox is due to the much larger number of potential
patients with less extensive disease. The correlation
Department of Preventive Cardiology, St Francis Hospital, Roslyn,
NY,USA
Yadon Arad. MD
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